JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Vivani Medical

Geschlossen

1.33 -3.62

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.31

Max

1.44

Schlüsselkennzahlen

By Trading Economics

Einkommen

-103K

-6.6M

Angestellte

42

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+171.74% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

11. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

19M

91M

Vorheriger Eröffnungskurs

4.95

Vorheriger Schlusskurs

1.33

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Apr. 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

Australian Flash PMI Bounce in April Conceals Deeper Worries

22. Apr. 2026, 23:33 UTC

Ergebnisse

SK Hynix Posts Record Quarterly Results Amid AI Boom

22. Apr. 2026, 22:40 UTC

Ergebnisse

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22. Apr. 2026, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22. Apr. 2026, 21:11 UTC

Ergebnisse

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22. Apr. 2026, 21:01 UTC

Ergebnisse

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22. Apr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22. Apr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22. Apr. 2026, 23:34 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22. Apr. 2026, 23:16 UTC

Ergebnisse

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22. Apr. 2026, 23:15 UTC

Ergebnisse

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22. Apr. 2026, 22:54 UTC

Ergebnisse

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22. Apr. 2026, 22:54 UTC

Ergebnisse

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22. Apr. 2026, 22:52 UTC

Ergebnisse

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22. Apr. 2026, 22:51 UTC

Ergebnisse

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22. Apr. 2026, 22:31 UTC

Ergebnisse

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22. Apr. 2026, 22:31 UTC

Ergebnisse

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22. Apr. 2026, 22:30 UTC

Ergebnisse

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22. Apr. 2026, 22:30 UTC

Ergebnisse

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22. Apr. 2026, 22:29 UTC

Ergebnisse

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22. Apr. 2026, 22:28 UTC

Ergebnisse

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22. Apr. 2026, 22:28 UTC

Ergebnisse

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22. Apr. 2026, 22:27 UTC

Ergebnisse

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22. Apr. 2026, 22:06 UTC

Market Talk
Ergebnisse

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22. Apr. 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22. Apr. 2026, 21:47 UTC

Ergebnisse

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22. Apr. 2026, 21:37 UTC

Ergebnisse

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22. Apr. 2026, 21:34 UTC

Ergebnisse

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22. Apr. 2026, 21:29 UTC

Ergebnisse

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22. Apr. 2026, 21:20 UTC

Market Talk
Ergebnisse

Tesla Expands Manufacturing to Chips -- Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

171.74% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD  171.74%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

$

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
help-icon Live chat